![Viruses | Free Full-Text | Urine and Free Immunoglobulin Light Chains as Analytes for Serodiagnosis of Hantavirus Infection Viruses | Free Full-Text | Urine and Free Immunoglobulin Light Chains as Analytes for Serodiagnosis of Hantavirus Infection](https://www.mdpi.com/viruses/viruses-11-00809/article_deploy/html/images/viruses-11-00809-g002.png)
Viruses | Free Full-Text | Urine and Free Immunoglobulin Light Chains as Analytes for Serodiagnosis of Hantavirus Infection
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
![Different roles of urinary light chains and serum light chains as potential biomarkers for monitoring disease activity in systemic lupus erythematosus [PeerJ] Different roles of urinary light chains and serum light chains as potential biomarkers for monitoring disease activity in systemic lupus erythematosus [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2022/13385/1/fig-1-full.png)
Different roles of urinary light chains and serum light chains as potential biomarkers for monitoring disease activity in systemic lupus erythematosus [PeerJ]
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
![KAPPA and LAMBDA assays, in serum and urine, for nephelometers and clinical chemistry analyzers - Clinical Laboratory int. KAPPA and LAMBDA assays, in serum and urine, for nephelometers and clinical chemistry analyzers - Clinical Laboratory int.](https://clinlabint.com/wp-content/uploads/sites/2/2023/09/CLI_230823_doc_imatge_KapLam.jpg.webp)
KAPPA and LAMBDA assays, in serum and urine, for nephelometers and clinical chemistry analyzers - Clinical Laboratory int.
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
![PDF] Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With PDF] Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With](https://d3i71xaburhd42.cloudfront.net/0d29e384d6133e84996104e7691e93748b7a294f/4-Table3-1.png)
PDF] Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With
![IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases](https://www.mdpi.com/ijms/ijms-24-09531/article_deploy/html/images/ijms-24-09531-g001.png)
IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases
![PDF) Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With PDF) Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With](https://www.researchgate.net/publication/325548624/figure/tbl2/AS:669120525787137@1536542173032/Distribution-of-Patients-With-Neoplastic-Monoclonal-Gammopathies-With-SFLCA-Results_Q320.jpg)
PDF) Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With
Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry | Journal of Proteome Research
![Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-022-00732-3/MediaObjects/41408_2022_732_Fig1_HTML.png)
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
![Light and heavy chain deposition revealed by repeat renal biopsy after inconclusive initial biopsy - Ramy M Hanna, Marina Barsoum, Andrae Vandross, Jonathan Zuckerman, Brian Cone, Shih-Fan Sun, Anthony Ghobran, Samuel Olanrewaju, Light and heavy chain deposition revealed by repeat renal biopsy after inconclusive initial biopsy - Ramy M Hanna, Marina Barsoum, Andrae Vandross, Jonathan Zuckerman, Brian Cone, Shih-Fan Sun, Anthony Ghobran, Samuel Olanrewaju,](https://journals.sagepub.com/cms/10.1177/2059300719844991/asset/images/large/10.1177_2059300719844991-fig1.jpeg)
Light and heavy chain deposition revealed by repeat renal biopsy after inconclusive initial biopsy - Ramy M Hanna, Marina Barsoum, Andrae Vandross, Jonathan Zuckerman, Brian Cone, Shih-Fan Sun, Anthony Ghobran, Samuel Olanrewaju,
![International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2008.307/MediaObjects/41375_2009_Article_BFleu2008307_Fig1_HTML.jpg)
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
![Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory](https://wardelab.com/wp-content/uploads/2020/06/18_2_4.jpg)